http://www.chemistrymag.org/cji/2003/053020ne.htm

  Mar. 1,  2003  Vol.5 No.3 P.20 Copyright cij17logo.gif (917 bytes)


Studies on chemical constituents of Camellia oleifera Abel

Li Bin,  Luo Yongming
(Jiangxi College of Traditional Chinese Medicine,  pharmacy department,   Nanchang 330006)

Received on Oct. 25,  2002; Supported by the National Natural Science Foundation of China (No.29862002)

Abstracts In this paper,  the chemical constituents in seeds cake of Camellia oleifera Abel were well studied,  and seven monocases were firstly isolated,  on the basis of its spectral and physicochemical evidence,  the structures of these compounds were elucidated to be: Dimethylterephthalate (I),   p-Hydroxybenzoic acid (II),  Kaemferol (III), Kaemferol-3-O-a-L-rhamnopyranosyl(1¡ú6)-b-D-glucopyranoside(IV),   Kaemferol-3-O-[2-O-b-D-glucopyranosyl-6- O-a-L-rhamnopyranosyl]-b-D-glucopyranoside(V),  Kaemferol-3-O-[2-O-b-D-xylopyranosyl-6-O-a-L- rhamnopyranosyl]-b-D-glucopyranoside (VI),   Kaemferol-3-O-[2-O-a-L- rhamnopyranosyl-6-O-b-D-xylopyranosyl]-b-D-glucopyranoside (VII). These compounds were first isolated and obtained from this plant.
Keywords Camellia oleifera; chemical constituents ; elucidation

Camellia oleifera Abel is a plant of Theaceae,  it is an important oil material in China. Its oil is used to treat intestinal disorders;its roots can be used to treat stomach-ache,  facial and external injury;and its defatted seeds cake can treat injury,   kill four pests and field snails. While it is prescribed,  there are many chemical constituents in the defatted seeds of Camellia oleifera Abel, such as saponins,  flavonols. Yet,   up to now there has no monocase been reported.For the sake of elucidating its bioactive constituents, exploiting its medical values and advancing its integrative usage,   defatted seeds cake of Camellia oleifera Abel had been well investigatied,  and, seven compounds were isolated ,  their structures were identified on the basis of its chemical and spectral evidence,  which are: Dimethylterephthalate(I),  p-Hydroxybenzoic acid(II) ,  Kaemferol (III),   Kaemferol-3-O-rhamno-pyranosyl (1¡ú6) glucopyranoside (IV),   Kaemferol-3-O-(2-O-glucopyranosyl-6-O-rhamnopyranosyl)-glucopyranoside (V),   Kaemferol-3-O-(2-O-xylopyranosyl-6-O-rham-nopyranosyl)-glucopyranoside (VI),   Kaemferol-3-O-(2-O-rhamnopyranosyl-6-O-xylopyranosyl)-glucopyranoside(VII). These compounds were first obtained from this plant.

1 INSTRUMENTS AND MATERIALS
General UV and IR spectra values were measured with a DU-650 and a FT-IR 2000 spectrophotometer, 1H- and 13C-NMR spectra were recorded on a INOVA-500 spectrometers.Chemical shifts are expressed as the value,  using TMS as an internal standard. RSI-MS data were measured with VG ZAB-HS mass spectrometer, Preparative HPLC was done with Dionex system
(Pump 580, 340SDAD diode arrays, YWG-C18column: F=10um10¡Á20mm,   detection,  UV 250nm); defatted seeds cake of Camellia oleifera were bought from Jiangxi Haitian Co.

2 EXTRACTION AND ISOLATION
The defatted seeds cake of Camellia oleifera Abel were broken into pieces,  and extracted with boiling water for 3 times.After filtration , the water extract was concentrated, and the concentrate was extracted with EtOAc and BuOH in turn. The EtOAc layer was evaporated,   and the extract was fractionated by silica gel column chromatography(eluation system: CHCl3-EtOAc),  2 white needle crystals and 1 yellow crystals were obtained from the eluate.After recrystallization, compound
I (80mg), II(130mg) and III(500 mg) were obtained.The BuOH layer was also evaporated,   and the extract was subjected to macroreticular resin column chromatography first(eluation system:EtOH-Water), and 40% EtOH eluate was collected and fractionated by column chromatography(eluation system:EtOH-Water),  4 crude yellow crystals were obtained , which were repurified by preparative HPLC(eluation system:BuOH-Water) to give 4 constituents , namely compound IV(70mg),  V(6mg),  VI(10mg),  VII(5mg).

3 ELUCIDATION
Compound
I Compound Iwas isolated as white needle crystals with a mp of 141-143ºC, and the molecular formula C10H10O4 .UV lmaxnm(MeOH): 201,  241,   285,  314. IR(KBr) nmaxcm-1 :3017, 2960, 1961, 1719 (C=O), 1537(benzene ring), 1504(benzene ring), 1434, 1280,   1263, 1107£¬1017,  954, 731. EI-MSm/z(%):194(M+, 37), 179(M-CH3, 10), 163(M-OCH3, 100),  135 (M-COOCH3, 30), 120(M-COOCH3-CH3, 15), 103(M-COOCH3-OCH3, 22), 92(7), 76(C6H4+, 21), 66(9). 1H-NMR(CDCl3) dppm:8.1(4H£¬S), 3.9(6H, S).On the basis of its spectral data,  compound I was: Dimethylterephthalate.
Compound
II Compound II was a white needle crystal with a mp of 216-218¡æ, and the molecular formula C7H6O3. UV lmaxnm(EtOH):252. IR(KBr)nmaxcm-1:3435(OH), 2936,  2866, 1736(C=O), 1462(benzene ring), 1380 (C-H), 1059 (C-O-C), 959,  801. EI-MS m/z(%)£º138(M+, 90), 121 (M-OH,   100), 93(M-COOH,   35), 77(C6H5+, 15), 65(C5H5+, 35), 45(-COOH,   100), 39(38).1H-NMR(CD3OD)dppm:6.8(2H,  m,  J=14Hz,  3Hz,  2.5Hz,  H-3,   H-5),  7.8(2H,  m,  J=14Hz,  3Hz,  2.5Hz,  H-2, H-6). 13C-NMR(CD3OD)dppm: 116.0(C-3, C-5), 122.7(C-1), 133.0(C-2, C-6), 163.4(C-4), 170.1(-COOH). Upon its spectral evidence , its structure should be p-Hydroxybenzoic acid.
Compound
III Compound III was isolated as yellow crystals with a mp of 275-277ºC, and the molecular formula C15H10O6. UV lmaxnm (MeOH)365, 327sh,  294sh, 265, 253sh. IR(KBr) nmaxcm-1 :3747(-OH, sharp band),   3321(-OH, broad band),  2463,  2364,  1654(C=O), 1607(benzene ring), 1503(benzene ring), 1378, 1180, 1101, 985, 820. EI-MS m/z(%): 286(M+, 100), 270, 258(M-CO, 27), 229(M-CO-CO, 25), 213(18), 153(A1+H, 21), 121(B2+, 60), 93(C6H5O+, 22), 77(C6H5+, 18), 69(30).1H-NMR (CD3COCD3) dppm:6.2(1H, d, J=2Hz, C6-H), 6.5(1H, d, J=2Hz, C8-H), 7.0(2H, dd,  J=9Hz, 3Hz, H-3, H-5'),  8.1(2H, dd,   J=9Hz, 3Hz, H-2',  H-6'). Its data of 13C-NMR(CD3OD) were in the table 1 .On the basis of relevant reference[1]and its spectral data,  compound III is 3, 5, 7, 4'-Tetrahydroxyflavone,  namely Kaemferol.
Compound
IV Compound IV was a yellow crystal with a mp of 223-224ºC, and the molecular formula C27H30O15 . UV lmaxnm (MeOH):351(band I),  319sh,  265(band II); lmaxnm (MeOH+NaOAc):383(band I),  352,  305sh,  273(band II). IR(KBr)nmaxcm-1 :3425(OH), 2930, 2361, 1684(C=O), 1563(benzene ring), 1507(benzene ring).1180(C-O), 887, 831, 582. FAB-MS m/z(%): 595(M+H, 27), 449(M-rha+H, 12),  287(Kaemferol+H, 44),   113(100),  87(14),  59(8). 1H-NMR (CD3OD) dppm:8.1(2H, d, J=7.5Hz,  H-2',   H-6'),  6.9(2H, d, J=7.5Hz, H-3',  H-5'),  6.4(1H, s, H-8),   6.2(1H, s, H-6),  5.2(1H, d, J=7Hz,  glc-H-1),  4.5(1H, s, rha-H-1),   3.2-3.8(10H£¬m£¬rha- and glc-H), 1.3-1.7(3H£¬m£¬rha-CH3). Its data of 13C-NMR(CD3OD) are in the Table 1 and Table 3. Because 6-C of glucose in 13C-NMR dropped from 60.8 to 68.6ppm, due to the glycosylation shift,  rhamnose should link to 6-C of glucose, so it was Kaemferol-3-O-a-L-rhamnopyranosyl(1¡ú6)-b-D-glucopyranoside[1, 2].
Compound
V Compound V was isolated as light-yellow crystals, and the molecular formula C33H40O20. UV lmaxnm (MeOH):346(band I),  265(band II);lmaxnm (MeOH+NaOAc);358(band I), 335, 271(band II).IR(KBr)maxcm-1: 3401(-OH, broad band), 2929(CH2), 1712(C=O), 1654(benzene ring), 1608(benzene ring), 1364, 1178, 1075(C-O), 842. RSI-MSm/z(%): 757(M+H, 70), 595(M-glc+H, 30), 449(M-glc-rha+H, 35), 287(Kaemferol+H, 100). 1H-NMR(DMSO-d6) dppm:12.6(1H, s, -OH), 9.5(1H, s, -OH), 8.0(2H,  d,  J=8.7Hz,  H-2',  H-6'),  6.9 (2H, d, J=8.7Hz, H-3',   H-5'),  6.4(1H, s, H-8), 6.2(1H, s, H-6),  5.6(1H, d, J=7Hz, glc-H-1''),   5.4(1H, m, glc-H-1''''),  4.6(1H, m, rha-H-1'''),  3.0-4.3(13H, m, 2glc-and rha-H), 0.8-1.4(3H, m, rha-CH3). Its data of 13C-NMR(CD3OD) are in the Table1 and Table3. Acid hydrolysis of Compound V with 5% H2SO4 provided L-rhamnose,  and D-glucose. According to relevant reference[3, 4],   compound V was elucidated as: Kaemferol-3-O-[2-O-b-D-glucopyranosyl-6-O-a-L-rhamnopyranosyl]-b-D-glucopyranoside.
Compound
VI Compound VI was isolated as yellow crystals,  and the molecular formula C32H38O19. UV lmaxnm (MeOH):347(band I),  266(band II); lmaxnm (MeOH+NaOAc):353(band I), 339(sh),  273(band II). IR nmaxcm-1 :3402(-OH, broad band),  2931,   1718(-CO),  1610(benzene ring), 1263, 1077(C-O-C),  892. RSI-MSm/z(%):727(M+H, 39), 595(M-xyl+H, 30),  449(M-xyl-rha+H, 10),   287(Kaemferol+H, 100). 1H-NMR(DMSO-d6) dppm: 9.5(1H, s, -OH),  8.0(2H, d, J=8.5Hz, H-2',  H-6'),  6.9(2H, d,  J=8.5Hz,  H-3',  H-5'),   6.4(1H, s, H-8),  6.2(1H, s, H-6),  5.3(1H, d, J=7Hz,  glc-H-1''),   5.0(1H, m, xyl- H-1'''),  4.6(1H, m, rha-H-1''''), 3.1-4.4(13H, m, glc-, xyl- and rha-H), 0.8-1.8(3H, m, rha-CH3). Its data of 13C-NMR(CD3OD) are in the Table 1 and Table 3.Acid hydrolysis of Compound VI with 5% H2SO4 provided L-rhamnose,   D-glucose and D-xylose. Compared relevant reference[3-6] with its spectral evidence, compound VI is Kaemferol-3-O-[2-O-b-D-xylopyranosyl-6-O-a-L- rhamno-pyranosyl]-b-D-glucopyranoside.
Compound
VII Compound VII was got as yellow crystals, and the molecular formula C32H38O19. UV lmaxnm (MeOH):349(band I),  266(band II); lmaxnm (MeOH+NaOAc):358(band I), 334(sh), 271(band II). IRnmaxcm-1: 3413(-OH, broad band),  2929, 1718(C=O),  1610(benzene ring), 1376, 1263, 1077(C-O-C), 893. RSI-MS m/z(%):727(M+H, 7), 581(M-rha+H),  449(M-rha-xyl+H, 10),  287(Kaemferol+H, 100). 1H-NMR(DMSO-d6) dppm:9.5(1H, s, -OH),  8.0(2H, d, J=8.3Hz, H-2',  H-6'),  6.9(2H, d, J=8.3Hz, H-3',  H-5'),  6.4(1H, s, H-8),  6.2(1H, s, H-6),  5.3 (1H, d, J=7Hz,  glc-H-1''),  5.0(1H, m, xyl-H-1''''), 4.6(1H, m, rha-H-1'''), 3.1-4.4(13H, m, glc-, xyl- and rha-H), 0.8-1.8(3H, m, rha-CH3). The data of 13C-NMR(CD3OD)were in the Table 1 and Table 3. Acid hydrolysis of Compound VI with 5% H2SO4 provided L-rhamnose and D-glucose, D-xylose. Compared its spectral evidence to relevant reference[3-6] , its structrue is Kaemferol-3-O-[2-O-a-L- rhamnopyranosyl-6-O-b-D-xylopyranosyl]-b-D-glucopyranoside .

Table 1 Comparing exerperimental data of 13C-NMR of aglycone in compound III, IV, V, VI, VII with the references.

   

Kaempferol

Compound IV Compound V Compound VI Compound VII
C

Reference
(DMSO-d6)

Experiment
(CD3OD)

Experiment
(CD3OD)

Experiment
(DMSO-d6)

Experiment (DMSO-d6)

Experimen
(DMSO-d6)

2
3
4
5
6
7
8
9
10
1
2
3
4
5
6
146.7
135.7
175.8
156.2
  98.2
163.8
  93.4
160.7
103.0
121.7
129.5
115.4
159.2
115.4
129.5
147.0
136.4
176.4
157.6
99.0
165.1
94.3
161.8
103.9
123.0
130.3
116.2
160.2
116.2
130.3
158.6
135.5
179.4
159.4
99.9
166.1
95.0
163.0
105.7
122.7
132.4
116.1
161.5
116.1
132.4
149.5
133.5
178.1
160.4
100.6
167.1
95.4
165.1
107.2
123.7
132.5
116.7
162.5
116.7
132.5
149.8
134.0
180.4
158.1
100.9
168.0
96.2
164.3
107.0
124.2
133.1
117.0
162.0
117.0
133.1
149.1
134.8
180.4
158.4
100.7
168.1
96.2
165.0
106.7
124.7
133.6
117.2
161.5
117.2
133.6

Table 2 The data of 13C NMR of three sugar in the references. (K means kaemferol)

C K-3-O-glc K-3-O-rha b-D-glc a-L- rha b-D-xyl
1
2
3
4
5
6
100.8
74.1
77.3
69.8
76.3
60.8
101.9
70.0
70.6
71.2
69.8
17.3
96.8
75.2
76.7
70.1
76.7
61.8
94.8
71.8
71.0
73.2
69.1
17.7
97.5
75.1
76.8
70.2
66.1

Table 3 Experimental data of 13C NMR of sugars in compound IV,  V,  VI,  VII

 

Compound IV
(CD3OD)

Compound V
(DMSO-d6)

Compound VI
(DMSO-d6)

Compound VII
(DMSO-d6)
C b-D-glc a-L- rha glc 1 rha glc 2 glc rha xyl glc xyl rha
1
2
3
4
5
6
104.6
75.8
77.2
71.4
78.1
68.6
102.4
72.1
72.3
73.9
69.7
17.9
104.8
76.8
78.1
72.5
79.2
68.0
103.4
79.4
70.3
71.9
69.7
17.9
105.2
73.7
76.1
69.4
76.1
60.6
104.6
76.5
77.8
72.2
78.5
68.0
102.7
79.1
71.3
71.9
70.6
17.7
105.5
76.8
78.8
73.4
66.2
105.6
76.2
77.0
72.6
78.9
68.4
107.0
82.0
77.8
73.8
66.9
101.9
70.1
70.3
72.9
68.3
18.0

REFERENCES
[1] Wang Zhixue, Zhang Yongyu, Liu Mingsheng et al. Journal of shenyang college of pharmacy (Shenyang Yaoxueyuan Xuebao),  1985,  2 (4): 284.
[2] Cheng Guiren, Jin Jinglan, Wen Yongxin. Acta pharmaceutica sinica
(Yaoxue Xuebao), 1987, 22 (3): 203.
[3] Xiao Chonghou. Chemistry of Chinese herbs (Zhongyao Huaxue). Shanghai: Shanghai scientific technology publishing house, 1996: 180.
[4] Yu Rongming,  LiXian,  ZhuTingru. Journal of shenyang college of pharmacy
(Shenyang Yaoxueyuan Xuebao), 1989, 6 (1): 58.
[5] WangYongqi,  Lu Lin,  JiangYang et al. Chinese traditional and herbal drugs
(Zhong Chaoyao), 1992,   23 (7): 341.
[6] Si Jianyong,  Chen Dihua,  Changqi et al. Acta pharmaceutica sinica
(Yaoxue Xuebao), 1994,  29 (2): 158.

¡¡

[ Back ] [ Home ] [ Up ] [ Next ]Mirror Site in USA  Europe  China  GBNet